Standout Papers
- High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. (1992)
- Platinum Resistance: The Role of DNA Repair Pathways (2008)
- AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. (1992)
- Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion (1985)
- Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. (1983)
- Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. (1987)
Immediate Impact
14 by Nobel laureates 18 from Science/Nature 113 standout
Citing Papers
A pan-cancer compendium of chromosomal instability
2022 StandoutNature
Engineering nanomedicine for glutathione depletion-augmented cancer therapy
2021 Standout
Works of Thomas C. Hamilton being referenced
Clinical studies of reversal of drug resistance based on glutathione
1998
Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer.
1996
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Thomas C. Hamilton | 8304 | 2302 | 4580 | 186 | 14.3k | |
| Donald S. Coffey | 7759 | 1025 | 1713 | 201 | 16.2k | |
| Patrick J. Casey | 14728 | 668 | 3380 | 245 | 19.1k | |
| John T. Isaacs | 10768 | 556 | 5391 | 303 | 21.0k | |
| Richard Kolesnick | 18155 | 503 | 2602 | 149 | 23.6k | |
| Roy Bicknell | 10123 | 640 | 3657 | 229 | 15.9k | |
| Donald P. McDonnell | 11441 | 1417 | 4287 | 271 | 23.5k | |
| Edwin G. Krebs | 14402 | 380 | 1874 | 149 | 20.5k | |
| Johannes V. Swinnen | 7974 | 960 | 1290 | 183 | 13.0k | |
| Danny R. Welch | 9418 | 1298 | 4625 | 257 | 13.6k | |
| Ernst Lengyel | 10450 | 2186 | 5619 | 188 | 18.3k |
All Works
Loading papers...